Rosetta Genomics Surges, Shares Rise 1000% in 8 Trading Days

Shares of Rosetta Genomics
are currently trading off the highs, though still up 70% on for the day. Shares rose as high as 23.34 on Thursday, up from around $2.00 on May 15, following a 1:15 reverse split. On May 16, the Israel-based molecular diagnostics company, announced that Novitas, the designated Medicare Administrative Contractor for the Company's miRview mets² assay, informed Rosetta that it plans to cover this assay for all Medicare beneficiaries. MiRview mets² accurately identifies the primary tumor of origin in primary and metastatic cancer including Cancer of Unknown or Uncertain Primary. Other related stocks moving in sympathy with Rosetta Genomics on Thursday include Complete Genomics
, up 35%, Vermillion
, up 25% and Genetic Technologies
, up 56%.

Posted In: NewsFDAGlobalHotMovers

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.